3Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The arthritis and rheumatism council low-dose glucocorticoid study group. N Engl J Med, 1995, 333:142 - 146.
4Bae SC, Corzillius M, Kuntz KM, et al. Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis. Rheum, 2003, 42:46 - 53.
5Buttgereit F, Straub RH, Wehling M, et al. Glucocorticoids in the treatment of rheumatic diseases. An update on the mechanisms of action. Arthritis Rheum, 2004, 50:3408 - 3417.
6Wilckens T. Glucocorticoids and immune function:physiological relevance and pathogenic potential of hormoral dysfunction. TiPS, 1995,16:193 - 197.
7Pincus T, Sokka T, Stein CM, et al. Are long-term very low dose prednisone for patients with rheumatoid arthritis as helpful as high dose are harmful? Ann Intern Med, 2002, 136:76 - 78.
8American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthrites: 2002 update. Arhritis Rheum, 2002, 46:328-346.
9Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.Lancet, 1997, 350:309 - 318.
10Landewe RBM, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis:long-term structural benefits of a brief intervention. Arthritis Rheum, 2002, 46: 347 -356.
